However, Vos and colleagues suggest that there are reasons to handle information about VUS carefully as nearly 80% of patients with VUS in BRCA1/2 believed that this finding was connected with a slightly high risk for cancer [30, 31]. The gene discussed is BRCA1; the disease is cancer.